In a report released on February 7, Kevin Heal from Argus Research maintained a Buy rating on Raymond James Financial (RJF – Research Report).

This was the stock's second consecutive day of gains.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

James maintained a positive outlook on Fortive Corporation (NYSE:FTV), increasing the price target from $85.00 to $90.00 while sustaining an Outperform rating. The adjustment follows Fortive's strong ...

Jeffrey Dobyns, the president of SageSpring Wealth Partners, says he and his colleagues were looking for greater freedom to ...

Raymond James is seeing a beneficial shift to advisory as well as recovering M&A activity, which may continue. Read why I ...

James maintained a Market Perform rating on Cerence Inc . (NASDAQ:CRNC) shares, reflecting a steady outlook after the company's recent financial performance. The stock has shown remarkable momentum, ...

In a report released today, William Katz from TD Cowen maintained a Hold rating on Raymond James Financial (RJF – Research Report), with a ...

LPL Financial welcomes a $345 million investment and planning team from Ameriprise as RayJay's employee advisor arm adds a ...

In earnings calls, both Raymond James and Ameriprise cited strong recruiting pipelines as they beat analysts’ income ...

Beauty (NYSE:ELF – Free Report) had its price target trimmed by Raymond James from $175.00 to $120.00 in a research report ...

Stock analysts at Seaport Res Ptn raised their Q3 2025 earnings per share estimates for Raymond James in a report released on ...